Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study-Reference-Cited by-同舟云学术

Long-Term Outcomes of COVID-19 and Risk Factors for Prolonged or Persistent COVID-19 in Lymphoma Patients: A Multicenter, Retrospective Cohort Study

Published:2024 Issue: Volume:39 Page:
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Lee Jung Ah¹^ORCID,Han Min¹^ORCID,Ahn Sangmin¹^ORCID,Lee Yongseop¹^ORCID,Yeom Joon-Sup¹^ORCID,Choi Jun Yong¹^ORCID,Ku Nam Su¹^ORCID,Jeong Su Jin¹^ORCID,Kim Jung Ho¹^ORCID,Kim Jin Seok²^ORCID,Chung Haerim²^ORCID,Cho Hyunsoo²^ORCID,Kim Yu Ri³^ORCID,Ahn Jin Young¹^ORCID

Affiliation:

1. Division of Infectious Diseases, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Division of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.

3. Division of Hematology, Department of Internal Medicine, Gangnam Severance hospital, Yonsei University College of Medicine, Seoul, Korea.

Funder

National Research Foundation of Korea

Yonsei University College of Medicine

Publisher

XMLink

Link

https://jkms.org/pdf/10.3346/jkms.2024.39.e263

Reference28 articles.

1. Prolonged in‐hospital stay and higher mortality after Covid‐19 among patients with non‐Hodgkin lymphoma treated with B‐cell depleting immunotherapy

2. IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY

3. COVID-19 Mortality and Severity in Cancer Patients and Cancer Survivors

4. COVID-19 in immunocompromised populations: implications for prognosis and repurposing of immunotherapies

5. Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient